Related references
Note: Only part of the references are listed.Phase I trial of single-dose temozolomide and continuous administration of O6-benzylguanine in children with brain tumors:: a Pediatric Brain Tumor Consortium report
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma:: New approaches to brain tumor therapy CNS consortium trial
Jon Weingart et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
JA Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi et al.
CLINICAL CANCER RESEARCH (2004)
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
ER Laws et al.
JOURNAL OF NEUROSURGERY (2003)
Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity
Y Hirose et al.
JOURNAL OF NEUROSURGERY (2003)
Share Paper
